Literature DB >> 19161419

Reconciling id, ego, and superego within interleukin-23.

Cristina M Tato1, Daniel J Cua.   

Abstract

The study of interleukin-23 (IL-23) over the past 8 years has led to the realization that cellular immunity is far more complex than previously appreciated, because it is controlled by additional newly identified players. From the analysis of seemingly straightforward cytokine regulation of autoimmune diseases, many limitations of the established paradigms emerged that required reevaluation of the 'rules' that govern the initiation and maintenance of immune responses. This information led to a major revision of the T-helper 1 (Th1)/Th2 hypothesis and discovery of an unexpected link between transforming growth factor-beta-dependent Th17 and inducible regulatory T cells. The aim of this review is to explore the multiple characteristics of IL-23 with respect to its 'id' in autoimmunity, 'ego' in T-cell help, and 'superego' in defense against mucosal pathogens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19161419     DOI: 10.1111/j.1600-065X.2008.00715.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  14 in total

1.  Posttranscriptional regulation of IL-23 expression by IFN-gamma through tristetraprolin.

Authors:  Xuesong Qian; Huan Ning; Jidong Zhang; Daniel F Hoft; Deborah J Stumpo; Perry J Blackshear; Jianguo Liu
Journal:  J Immunol       Date:  2011-04-22       Impact factor: 5.422

2.  Quantitative events determine the differentiation and function of helper T cells.

Authors:  Anne O'Garra; Leona Gabryšová; Hergen Spits
Journal:  Nat Immunol       Date:  2011-04       Impact factor: 25.606

Review 3.  T-bet-/- RAG2-/- ulcerative colitis: the role of T-bet as a peacekeeper of host-commensal relationships.

Authors:  Wendy S Garrett; Laurie H Glimcher
Journal:  Cytokine       Date:  2009-08-08       Impact factor: 3.861

4.  Autoimmunity.

Authors:  Jeffrey A Bluestone; Vijay Kuchroo
Journal:  Curr Opin Immunol       Date:  2009-10-30       Impact factor: 7.486

Review 5.  IL-23 in infections, inflammation, autoimmunity and cancer: possible role in HIV-1 and AIDS.

Authors:  Govardhana Rao Yannam; Tanuja Gutti; Larisa Y Poluektova
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-24       Impact factor: 4.147

Review 6.  Interleukin-23: as a drug target for autoimmune inflammatory diseases.

Authors:  Chunlei Tang; Shu Chen; Hai Qian; Wenlong Huang
Journal:  Immunology       Date:  2012-02       Impact factor: 7.397

7.  Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550).

Authors:  Kamran Ghoreschi; Michael I Jesson; Xiong Li; Jamie L Lee; Sarbani Ghosh; Jason W Alsup; James D Warner; Masao Tanaka; Scott M Steward-Tharp; Massimo Gadina; Craig J Thomas; John C Minnerly; Chad E Storer; Timothy P LaBranche; Zaher A Radi; Martin E Dowty; Richard D Head; Debra M Meyer; Nandini Kishore; John J O'Shea
Journal:  J Immunol       Date:  2011-03-07       Impact factor: 5.422

8.  Comprehensive sequence analysis of the human IL23A gene defines new variation content and high rate of evolutionary conservation.

Authors:  Elizabeth A Tindall; Vanessa M Hayes
Journal:  DNA Res       Date:  2010-02-12       Impact factor: 4.458

9.  Inflammatory monocyte recruitment is regulated by interleukin-23 during systemic bacterial infection.

Authors:  Mohanalaxmi Indramohan; Amy N Sieve; Timothy J Break; Rance E Berg
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

Review 10.  From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited.

Authors:  Katia Boniface; Bianca Blom; Yong-Jun Liu; René de Waal Malefyt
Journal:  Immunol Rev       Date:  2008-12       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.